CanaQuest Medical Corp (OTC: CANQF)
Sep. 18, 2022
Courtesy ofCanaQuest Medical Corp.
About: CanaQuest Medical is an award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder “PTSD,” including addiction.
Most popular related searches
post-traumatic stress disorder
preclinical trial
central nervous system
drug discovery and development
clinical trial
drug candidate
omega-3
mental health
anxiety depression
neurology condition
cannabidiol cbd
brain barrier
blood brain
nervous system
PPAR receptor
stress disorder
pharmaceutical drug
endocannabinoid system
opioid addiction
clinical stage
brain blood
drug identification
clinical study
drug delivery
brain medicine
drug discovery
drug discovery development
cannabidiol
epilepsy
drug approval
depression
anxiety
neurology
cannabinoid
Stay in the loop!
Select your areas of interest to receive industry updates.